Evidence map›Paper›PMID 34821568›Full record

ArticleJMIR research protocols2021

Outcomes of Digital Biomarker-Based Interventions: Protocol for a Systematic Review of Systematic Reviews.

Hossein Motahari-Nezhad, Márta Péntek, László Gulácsi, Zsombor Zrubka

Abstract read
In one paragraph

Article in JMIR research protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hossein Motahari-Nezhad *Doctoral School of Business and Management, Corvinus University of Budapest, Budapest, Hungary.ORCID https://orcid.org/0000-0002-1028-4460
Márta PéntekHealth Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary.ORCID https://orcid.org/0000-0001-9636-6012
László GulácsiHealth Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary.ORCID https://orcid.org/0000-0002-9285-8746
Zsombor Zrubka *Health Economics Research Center, University Research and Innovation Center, Obuda University, Budapest, Hungary.ORCID https://orcid.org/0000-0002-1992-6087

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigital biomarkers are defined as objective, quantifiable, physiological, and behavioral data that are collected and measured using digital devices such as portables, wearables, implantables, or digestibles. For their widespread adoption in publicly financed health care systems, it is important to understand how their benefits translate into improved patient outcomes, which is essential for demonstrating their value.

objectiveThe paper presents the protocol for a systematic review that aims to assess the quality and strength of the evidence reported in systematic reviews regarding the impact of digital biomarkers on clinical outcomes compared to interventions without digital biomarkers.

methodsA comprehensive search for reviews from 2019 to 2020 will be conducted in PubMed and the Cochrane Library using keywords related to digital biomarkers and a filter for systematic reviews. Original full-text English publications of systematic reviews comparing clinical outcomes of interventions with and without digital biomarkers via meta-analysis will be included. The AMSTAR-2 tool will be used to assess the methodological quality of these reviews. To assess the quality of evidence, we will evaluate the systematic reviews using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) tool. To detect the possible presence of reporting bias, we will determine whether a protocol was published prior to the start of the studies. A qualitative summary of the results by digital biomarker technology and outcomes will be provided.

resultsThis protocol was submitted before data collection. Search, screening, and data extraction will commence in December 2021 in accordance with the published protocol.

conclusionsOur study will provide a comprehensive summary of the highest level of evidence available on digital biomarker interventions, providing practical guidance for health care providers. Our results will help identify clinical areas in which the use of digital biomarkers has led to favorable clinical outcomes. In addition, our findings will highlight areas of evidence gaps where the clinical benefits of digital biomarkers have not yet been demonstrated. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/28204.

Indexed as

AMSTAR-2biomarkersclinical outcomedigestablesdigital biomarkerdigital healthGrading of Recommendations, Assessment, Development and Evaluationimplantsinterventionsmeta-analysismobile healthoutcomeportablesreviewsystematic reviewwearables

Identifiers

PMID34821568
PMCPMC8663678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.